Immunotherapy Resistance and Advancing Adaptive Cell Therapeutics

7,641
Total downloads
27k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 22 Apr 2025

Advancing personalized, predictive, and preventive medicine in bladder cancer: a multi-omics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery

Han Yan
Xinyu Ji
Bohan Li

doi 10.3389/fimmu.2025.1572034

1,154 views

MINI REVIEW

Published on 28 Mar 2025

γδT cells, a key subset of T cell for cancer immunotherapy

Jianzhen Lv
Zheng Liu
Xiangting Ren
Siyuan Song
Yan Zhang
Yi Wang

doi 10.3389/fimmu.2025.1562188

1,664 views

REVIEW

Published on 21 Mar 2025

New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies

Karolina Rassek
Jan Misiak
Tomasz Ołdak
Natalia Rozwadowska
Grzegorz Basak
Tomasz Kolanowski

doi 10.3389/fimmu.2025.1561174

1,686 views

MINI REVIEW

Published on 12 Feb 2025

Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies

Jianyang Ao
Mingtai Hu
Jinghan Wang
Xiaoqing Jiang

doi 10.3389/fimmu.2025.1559465

1,933 views

MINI REVIEW

Published on 05 Feb 2025

Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer

Lijuan Qin
Yuan Li
Juan Liu
Xiaoqin An

doi 10.3389/fimmu.2025.1554256

2,533 views

REVIEW

Published on 14 Jan 2025

Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis

Zhiyong Wan
Meng Cui
Jia Yang
Dan Liao
Junliang Chen
Fanmin Li
Yin Xiang
Zhiwei Cui
Yang Yang

doi 10.3389/fonc.2024.1531219

609 views

REVIEW

Published on 29 Nov 2024

Breaking barriers: advancing cellular therapies in autoimmune disease management

Yanhong Fu
Chunjing Feng
Shan Qin
Zhiyao Xing
Chong Liu
Zichuan Liu
Hongjian Yu

doi 10.3389/fimmu.2024.1503099

2,522 views
1 citation

ORIGINAL RESEARCH

Published on 24 Jun 2024

CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma

Michael W. Moles
Henry Erdlei
Lutz Menzel
Marialucia Massaro
Agnese Fiori
Mario Bunse
Moritz Schrimpf
Kerstin Gerlach
Venugopal Gudipati
7 more
Armin Rehm

doi 10.3389/fimmu.2024.1383136

4,046 views
3 citations

CASE REPORT

Published on 11 Jun 2024

Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study

Laura Patton
Bethany Monteith
Paul Heffernan
Thomas Herzinger
Brooke E. Wilson

doi 10.3389/fonc.2024.1394543

1,659 views
3 citations

ORIGINAL RESEARCH

Published on 19 Apr 2024

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

Heleen Hanssens
Fien Meeus
Yannick De Vlaeminck
Quentin Lecocq
Janik Puttemans
Pieterjan Debie
Timo W. M. De Groof
Cleo Goyvaerts
Kim De Veirman
1 more
Nick Devoogdt

doi 10.3389/fimmu.2024.1389018

2,942 views

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy
Vaccines and Molecular Therapeutics
T Cell Biology

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

27kTopic views
18kArticle views
7,641Article downloads

View impact

Articles

Advancing personalized, predictive, and preventive medicine in bladder cancer: a multi-omics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery

γδT cells, a key subset of T cell for cancer immunotherapy

New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies

Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies

Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer

Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis

Breaking barriers: advancing cellular therapies in autoimmune disease management

CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma

Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Vaccines and Molecular Therapeutics

T Cell Biology

Participating Journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy